Found 0 matching trials
Pegvisomant And Sandostatin LAR Combination Study PHASE4 The purpose of this study is to compare the safety and tolerability of comb...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients PHASE4 This study will assess the efficacy of 8 months treatment of Sandostatin® L...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours PHASE3 This was a multicenter, stratified, open, randomized, comparator-controlled...
Show More Location
Cedars-Sinai Medical Center Samuel Oschin Cancer Center
Learn More & Join Trial
Surgical Debulking of Pituitary Adenomas PHASE4 This is a randomized, multicenter trial with stratification done by a singl...
Show More Location
New York University School of Medicine
Learn More & Join Trial
Acromegaly Combination Treatment Study NA In this study the investigators will evaluate whether combination low dose ...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Prader-Willi Syndrome and Appetite PHASE3 Excessive weight gain is a cardinal feature of Prader-Willi syndrome (PWS) ...
Show More Location
Children's and Women's Health Centre of British Columbia
Learn More & Join Trial
5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors PHASE2 Well differentiated neuroendocrine carcinomas have low proliferative activi...
Show More Location
Federico Castiglione
Learn More & Join Trial
Pediatric Hypothalamic Obesity PHASE4 This trial is being conducted in pediatric patients with Hypothalamic Obesi...
Show More Location
Phoenix Children'S Hospital
Learn More & Join Trial
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis PHASE2 To evaluate in combination with corticosteroid and local standard medical c...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer PHASE3 RATIONALE: Octreotide may be effective in preventing or controlling diarrhe...
Show More Location
Mobile Infirmary Medical Center
Learn More & Join Trial